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Background: The aim of this study were to describe acute care of ischemic stroke patients and adherence to
performance measures, as well as the outcomes of these events, in a sample of patients treated in public hospitals
in Chile.
Methods: We retrospectively reviewed the medical charts of patients with ischemic stroke from a sample of seven
public hospitals in the Metropolitan Region of Santiago. We analyzed adherence to the following evidence-based
measures: clinical evaluation at admission, use of intravenous thrombolysis, dysphagia screening and prescription of
antithrombotic therapy at discharge. As outcome measures we analyzed post-stroke pneumonia and 30-day case-
fatality. We used a logistic regression model by each outcome with generalized estimating equations, which
accounted for clustering of patients within hospitals and included sex, age (years), clinical status at admission
(reduced level of consciousness, speech disturbance, aphasia and hemiplegia), comorbidities, dysphagia screening
and neurological evaluation at admission as measures of acute stroke care.
Results: We reviewed the charts of 677 patients, of which 52.3% were men. The mean age was 69.8 years in
women and 66.3 years in men. Diagnosis of stroke was confirmed by a computed tomography scan within
4.5 hours of symptom onset in only 9.6% of the patients. Intravenous thrombolysis was administered in 1.7%.
Dysphagia screening was performed in 12.1% (95% CI 9.7-15.0) and antithrombotic therapy was prescribed in 68.9%
(95% CI 64.6-72.9). Pneumonia was diagnosed in 23.6% (95% CI 20.4-27.2). Thirty-day fatality was 8.7% (95% CI
6.7-11.3). The variables independently associated with 30-day case fatality were age (OR 1.08, 95% 1.06-1.10),
pneumonia (OR 7.7, 95% 95% CI 4.0-14.7), aphasia (OR 2.4, 95% CI 1.1-5.6), reduced level of consciousness (OR 2.4,
95% CI 1.3-4.4), and speech disturbance (OR 1.4, 95% CI 1.0-1.9). No association was found between 30-day case
fatality and dysphagia screening or neurological evaluation at admission. The factors associated with post-stroke
pneumonia were female sex (OR 1.6, 95% CI 1.0-2.3), age (OR 1.04 95% CI 1.03-1.05), diagnosis of diabetes (OR 1.8,
95% CI 1.4-2.4), aphasia (OR 2.0, 95% CI 1.5-2.7), hemiplegia (OR 1.6, 95% CI 1.1-2.4), and reduced level of
consciousness on admission (OR 3.4, 95% CI 2.1-5.5). No association was found between pneumonia and dysphagia
screening or neurological evaluation at admission.
Conclusions: Adherence to evidence-based performance measures was low. Administration of intravenous
thrombolysis was particularly low and diagnostic confirmation of ischemic stroke was delayed. The occurrence of
post-stroke pneumonia was frequent and should be reduced. To improve acute stroke care in Chile, organizational
change in the health service is urgently needed.
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The global burden of stroke is greater in middle and
low-income than in high-income countries [1,2]. In
Chile, the annual adjusted incidence of stroke is 97.4 per
100,000 inhabitants [3], and these events cause 9% of all
deaths. In the population aged 45–84 years, 65% of
strokes are ischemic, corresponding to an incidence rate
for a first event of 59.6 per 100,000 inhabitants, with a
mean age of 68.6 years in women and 64.7 in men [4].
Only a few interventions have been demonstrated to
improve prognosis after an acute ischemic stroke. Such
interventions include admission to an organized Stroke
Unit, which reduces death and disability and cost in all
types of stroke irrespective of age or sex [5], and enhan-
cing adherence to important clinical practice guideline
recommendations [6]. The chance of a good outcome at
6 months is increased by aspirin administration within
48 hours of symptom onset, while, in large hemi-
spheric infarctions, 3-month mortality is decreased
by hemicraniectomy within 48 hours of symptom
onset to prevent brain herniation [7].
The only specific drug treatment with proven cost-
effectiveness in reducing the disability caused by ische-
mic stroke is intravenous thrombolysis with recombinant
tissue plasminogen activator (rtPA) [8,9]. The effective-
ness of this procedure decreases according to the inter-
val between stroke onset and the start of treatment,
which is not recommended after 270 minutes [10,11].
National [12] and international clinical guidelines
recommend the use of thrombolysis in the acute man-
agement of ischemic stroke [9,13,14]. Although these
recommendations were made several years ago, studies
in high-income countries have reported low use of
intravenous thrombolysis, even among patients admitted
to hospital within the therapeutic window [15]. In
Australia, intravenous thrombolysis is used in 7% of all
patients with ischemic stroke, mainly in hospitals with
stroke units [16]. A study performed in the USA found
that intravenous thrombolysis was used in 2.4% of ad-
missions for ischemic stroke [17]. Isolated publications
in low-middle income countries have reported that the
use of this treatment is even lower [18].
The systematic use of clinical guidelines depends
largely on health service organization. In the USA, the
use of intravenous thrombolysis and other evidence-
based performance measures has significantly improved
in hospitals adhering to the Get with the Guidelines-
Stroke program [19,20]. In Spain, a Stroke Program audit
of the quality of in-hospital stroke care reported signifi-
cant improvements in preventive measures for concomi-
tant conditions or potential complications, as well as in
the early evaluation of the need for care [21]. After
stroke services were redesigned in Australia, brain
imaging within 24 hours after stroke and prescription ofanti-thrombotic therapy at discharge significantly in-
creased [6].
In Chile, the system of Explicit Health Guarantees
(EHG) for ischemic stroke was implemented in 2005,
which guaranteed access to confirmation of diagnosis
and acute treatment of strokes to 91.0% of the Chilean
population, including clinical practice guidelines with
evidence-based recommendations [12]. The develop-
ment of organized Stroke Units is only now starting to
happen in Chile and was not included as part of the
2005 EHG for ischemic stroke.
The aim of this study was to assess acute care of ische-
mic stroke and adherence to performance measures, as
well as to identify the outcome of these events, in a
sample of patients treated in public hospitals in Chile
from 2007 to 2009.
Methods
We retrospectively reviewed the medical charts of a
sample of patients aged 15 years and above, hospitalized
with a diagnosis of ischemic stroke in 7 out of 22 public
hospitals of the Metropolitan Region of Santiago, Chile.
Overall, the selected hospitals provide health care to an
adult population of 5,375,908 persons, representing
40.4% of the Chilean population. In 2009, these hospitals
received 85.3% of all admissions for stroke in the Metro-
politan Region of Santiago and 55.3% of those in the
country as a whole, admitted 150 to 878 patients per
year. These hospitals are referral centers for stroke care
in each of the six territorially organized health services
of the public health care network in the Metropolitan Re-
gion of Santiago. All study hospitals had adult emergency
services and access to on-site computed tomography (CT)
24 hours per day and 365 days per year. We excluded
pediatric hospitals (n = 5), subspecialty institutes (n = 7),
hospitals without emergency departments (n = 3), and com-
munity hospitals without CT scanners (n = 8). The sam-
pling frame was the Management System of the Explicit
Health Guarantees, which is mandated to routinely register
all patients with ischemic stroke admitted to hospitals in
the public sector. All patients with a main admission diag-
nosis of ischemic stroke (ICD-10 I63) between August 2007
and August 2009 were included. The patients were identi-
fied through their national identification number, sex, age
at event, and the admitting hospital. The study protocol
was approved by the Ethics Committee of the Faculty of
Medicine of the Universidad Mayor, Santiago, Chile.
Data collection
A structured case report form was designed and tested
in three hospitals in the Metropolitan Region of Santiago.
Data were extracted by a team of researchers external to
the selected hospitals, composed of clinical nurses with
experience in adult emergency departments. All nurses
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If the measures were not documented, they were consid-
ered not to have been performed.
To check the quality of data collection, an external
audit was carried out by blinded and independent
researchers. This audit consisted of double data collec-
tion of approximately 10% of the patients admitted to
each hospital and selected randomly from the patient
lists. To determine consistency among raters, interrater
reliability was analyzed using the Kappa statistic.
Study variables
The variables were selected based on a review of the
literature on the acute management of ischemic
stroke, evidence-based recommendations in protocols
and clinical practice guidelines, expert evaluation
(neurologists, clinical epidemiologists and emergency
department nurses), and the availability of data in
the medical chart. We chose the performance mea-
sures that we believed to be most indicative of the
outcomes of case fatality and pneumonia. Adherence
to the following performance measures was included:
a) completeness of the data and time from symptom
onset to CT confirmation of the ischemic stroke
diagnosis by neurologist, b) the time interval from
symptom onset to CT scan and diagnostic confirm-
ation of ischemic stroke by neurologist, c) the
percentage of patients who underwent dysphagia
screening through a simple, valid bedside test before
receiving any food, fluids or medication and within
48 hours of hospital admission (excluding comatose
patients), d) the proportion of patients with neuro-
logical evaluation on admission through the Glasgow
Coma Scale [22], 3) the proportion of ischemic
stroke patients with prescribed antithrombotic ther-
apy at hospital discharge, and f ) the percentage of
patients administered intravenous thrombolysis. We
also included the occurrence of post-stroke pneumo-
nia diagnosed after hospital admission, and 30-day
case fatality. Pneumonia was defined as pneumonia
occurring during hospitalization, documented by a
physician, and requiring antibiotic treatment.
Because patients can die after hospital discharge,
survival was determined through the link between the
variables identifying ischemic stroke patients (complete
name and unique identity number) and the official mor-
tality register. This register is exhaustive and the cause
of death was medically certified in 99.3% of deaths in
2007, while 2.9% of deaths were classified as poorly
defined [23]. The death coding process is carried out
according to standardized and centralized criteria in the
Statistics and Health Information Department of the
Ministry of Health and the main cause of death is coded
according to the ICD-10 classification.Statistical analysis
The sample size was calculated to provide an estimated
15.0% prevalence of in-hospital pneumonia, 2.5% preci-
sion, a 95% confidence interval, and 12% predicted
losses. A population of 10,467 ischemic stroke patients
in the Metropolitan Region of Santiago was used to esti-
mate the sample. The overall sample consisted of 821
patients. Due to differences in the volume of patients ad-
mitted to the study hospitals, stratified random sampling
by hospital (stratum) was used to select ischemic stroke
patients from the list of patients. In each hospital, an
equal number of patients (n = 117) were randomly sam-
pled, except in one hospital where 119 patients were se-
lected. Thus, the probability of including a patient in the
sample depended on the hospital’s size. According to the
sample design and to obtain representative results, sam-
pling weights were calculated as the inverse probability
of being included in the study. Descriptive results were
weighted.
Performance measures were calculated by taking the
number of patients receiving a particular intervention as
the numerator, and the total number of patients eligible
for this intervention as the denominator. Proportions
and 95% confidence intervals were calculated for the
population characteristics and for the study variables.
Proportions were compared among hospitals by using
the Kruskal-Wallis test.
To estimate the adjusted odds ratios of 30-day fatality
and in-hospital pneumonia according to adherence to
selected performance measures, dysphagia screening and
neurological evaluation, we used multivariable logistic
regression with generalized estimating equations (GEE),
which accounted for the correlations among patients
within hospitals. The model for 30-days fatality was ad-
justed by the patients’ demographic characteristics (sex
and age at event), comorbidities (diabetes and hyperten-
sion), in-hospital pneumonia (because it is an important
predictor of post-stroke fatality) [24] and clinical status
at admission (aphasia, hemiplegia, reduced level of con-
sciousness, and speech disturbance). These variables
showed the degree of neurological impairment assessed
within the first few hours after arrival at the hospital and
were included in the regression model as proxies of
stroke severity [25]. The model for post-stroke pneumo-
nia was adjusted using the same patient’s characteristics,
and excluding pneumonia. A p-value of < 0.05 was con-
sidered statistically significant and odds ratios with their
95% CI were calculated.
Potential selection biases were assessed by comparing
the distributions of sex, mean age, and the proportion of
30-day fatality among participants and non-participants
in the study. The Chi-squared test was used to compare
differences in sex and 30-day fatality, and Student’s t-test
was used to compare age.
Table 1 Characteristics of the study population
n Percentage (95% CI)
Sex
Male 359 52.3 (48.2-56.4)
Female 318 47.7 (43.6-51.8)
Age
<=50 years 82 12.6 (10.1-15.7)
51 - 60 years 91 13.9 (11.3-17.0)
61 - 70 years 180 26.4 (23.0-30.2)
71- 80 years 206 30.2 (26.5-34.1)
More than 80 years 114 16.9 (14.0-20.2)
Comorbidities
Diagnosis of diabetes 197 28.5 (25.0-32.3)
History of hypertension 533 77.0 (73.3-80.4)
Hospitals
Hospital 1 99 25.5
Hospital 2 64 8.6
Hospital 3 110 13.0
Hospital 4 98 3.8
Hospital 5 98 12.6
Hospital 6 105 18.9
Hospital 7 103 17.7
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tical Package for the Social Sciences (SPSS) program,
version 20.0.
Results
Of 821 patients selected, 677 were included in the study.
We excluded 124 patients because their medical charts
could not be found after five searches on different dates
or because the charts contained insufficient information
for diagnosis of an ischemic stroke (Figure 1). Twenty
patients without confirmed ischemic stroke were also
excluded. The overall interrater agreement was 0.75, and
more than 85% of the variables achieved kappa values
above 0.6 (using the Landis & Koch classification) [26].
The number of excluded patients was significantly
greater in hospital 2 than in the remaining hospitals.
Overall, there were no significant differences between
participants and non-participants in sex distribution
(p-value: 0.84), mean age (p-value: 0.60), or 30-day fatality
(p-value: 0.27).
Men accounted for 52.3% of the sample (Table 1). The
mean age was 69.8 years (95% CI 68.0- 71.6) in women
and 66.3 years (95% CI 64.9- 67.6) in men. A history of
hypertension was found in 77.0% and a diagnosis of dia-
betes mellitus in 28.5%. There were no significant differ-
ences among hospitals in patient characteristics (Table 2).
The percentage of patients with complete information
on the date and time of symptom onset was 47.0% (95%
CI 42.9-51.1). Significant differences were found among
hospitals (p <0.05), with a range of between 36.7% andTotal number of patients with 
ischemic stroke admitted to public 
hospitals in the metropolitan region 
of Santiago, Chile (n = 10,467 
(August 2007-August 2009)
Total number of patients with 
ischemic stroke included 
n= 821
Random selection by hospital 
Total number of 
patients reviewed 
n= 677
Total number of 
patients not reviewed 
n=144
No medical history available or 
insufficient data recorded n=124
Patients with cerebral infarction not 
confirmed as ischemic, n=20
Figure 1 Flow chart of patient inclusion in the study.
Table 2 Characteristics of the study population by hospital
Hospital 1 Hospital 2 Hospital 3 Hospital 4 Hospital 5 Hospital 6 Hospital 7 Kruskall-
Wallis
p-value
% CI (95%) % CI (95%) % CI (95%) % CI (95%) % CI (95%) % CI (95%) % CI (95%)
Lower Upper Lower Upper Lower Upper Lower Upper Lower Upper Lower Upper Lower Upper
Sex Men 47.5 37.7 57.5 57.8 45.1 69.5 47.3 38.1 56.8 55.1 45.0 64.8 58.2 48.0 67.7 57.1 47.4 66.4 50.5 40.8 60.2 0.487
Women 52.5 42.5 62.3 42.2 30.5 54.9 52.7 43.2 61.9 44.9 35.2 55.0 41.8 32.3 52.0 42.9 33.6 52.6 49.5 39.8 59.2
Total 100 100 100 100 100 100 100
Age (years) <=50 15.8 9.7 24.7 18.8 10.8 30.5 7.3 3.6 14.0 13.3 7.8 21.7 8.2 4.1 15.7 11.4 6.5 19.2 13.6 8.1 21.8 0.219
51 - 60 12.6 7.2 21.1 12.5 6.3 23.4 10.9 6.2 18.4 10.2 5.5 18.1 17.3 11.0 26.3 13.3 8.0 21.4 17.5 11.2 26.2
61 - 70 25.3 17.4 35.1 23.4 14.5 35.7 29.2 21.3 38.5 29.6 21.3 39.5 22.4 15.2 31.9 31.4 23.2 41.1 24.3 16.9 33.6
71- 80 28.4 20.1 38.5 32.8 22.2 45.5 28.2 20.4 37.4 32.7 24.0 42.7 31.6 23.1 41.6 26.7 19.0 36.1 35.0 26.2 44.8
80 and older 17.9 11.3 27.1 12.5 6.3 23.4 24.5 17.3 33.6 14.3 8.6 22.9 20.4 13.5 29.7 17.1 11.0 25.7 9.7 5.2 17.3
Total 100 100 100 100 100 100 100
Diabetes Without
diagnostic
72.7 63.0 80.7 68.8 56.1 79.1 69.1 59.8 77.1 69.4 59.4 77.8 70.4 60.5 78.7 78.1 69.0 85.1 67.0 57.2 75.5 0.678
With
diagnostic
27.3 19.3 37.0 31.3 20.9 43.9 30.9 22.9 40.2 30.6 22.2 40.6 29.6 21.3 39.5 21.9 14.9 31.0 33.0 24.5 42.8
Total 100 100 100 100 100 100 100
Hypertension Without
diagnostic
31.3 22.8 41.3 20.3 12.0 32.3 19.1 12.7 27.6 16.3 10.2 25.2 20.4 13.5 29.7 24.8 17.3 34.1 16.5 10.4 25.1 0.128
With
diagnostic
68.7 58.7 77.2 79.7 67.7 88.0 80.9 72.4 87.3 83.7 74.8 89.8 79.6 70.3 86.5 75.2 65.9 82.7 83.5 74.9 89.6
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and time of CT scans and diagnostic confirmation by a
neurologist was recorded. Recording of the date and
time of CT scans was significantly lower in two hospitals
than in the remaining hospitals (p <0.05).
A CT scan was performed within 24 hours of symptom
onset in only 45.2% of patients, while the interval be-
tween symptom onset and CT scan could not be
determined in 21.1% of the medical charts (95% CI 17.8-
24.9). An interval of up to 270 minutes between symp-
tom onset and CT-based confirmation of the diagnosis
occurred in 9.6% of the patients (95% CI 7.4-12.2). This
percentage varied among hospitals, ranging from 3.6%
(95% CI 1.4-9.4) to 14.3% (95% CI 8.6-22.7) (Figure 2).
Intravenous thrombolysis was used in 15 patients in
only two hospitals (Table 3), representing 1.7% (95% CI
1.0-3.0). Neurological evaluation on admission using a
standard clinical scale was performed in 52.4% (95% CI
48.3-56.5), with significant differences among hospitals
(p = 0.03). Dysphagia screening was carried out in 12.1%
(95% CI 9.7-15.0) of patients with indication for this
procedure, with significant differences among hospitals,
ranging from 4.2% to 25.4% (p <0.0001). Antithrombotic
therapy was prescribed at discharge in 68.9% (95% CI
64.6-72.9), with significant differences among hospitals
(p <0.0001). In-hospital pneumonia occurred in 23.6%
(95% CI 20.4-27.2), but this percentage was much higher
in hospital 3: 41.9% (95% CI 32.9-51.4) compared with
the remaining hospitals (p < 0.0001). Case-fatality at 30 -
days was 8.7% (95% CI 6.7-11.3) with significant differ-
ences among centers (p <0.0001), hospital 5 showing the
highest mortality (Figure 3).Figure 2 Time interval from symptom onset to CT scan by hospital.The GEE for 30-day case-fatality (Table 4), which in-
cluded the effect of clustering patients in hospital,
showed that demographic and clinical variables inde-
pendently associated with an increased probability of
death were age (OR 1.08, 95% CI 1.06-1.10), post-stroke
pneumonia (OR 7.65, 95% CI 3.98-14.72), and reduced
level of consciousness (OR- 2.41, 95% CI 1.32-4.41) at
hospital admission. No association was found between
the performance of neurological evaluation (OR 2.02,
95% CI 0.77-5.30) and dysphagia screening (OR 0.52,
95% CI 0.26-1.04) and the likelihood of 30-day fatality.
For post-stroke pneumonia (Table 4), the demographic
and clinical variables independently associated with an
increased risk of pneumonia were female sex (OR 1.55,
95% CI 1.03-2.33), age (OR 1.04, 95% CI 1.03-1.05), dia-
betes (OR 1.79, 95% CI 1.35-2.38), aphasia (OR 1.97,
95% CI 1.45-2.69), hemiplegia (OR 1.60, 95% CI 1.08-
2.38), and reduced level of consciousness (OR 3.37, CI
95% 2.07-5.48). No association was found between dys-
phagia screening and neurological evaluation and post-
stroke pneumonia.
Discussion
In this study, we found that adherence to evidence-
based performance measures in the acute care of
ischemic stroke in a sample of public hospitals in the
Metropolitan Region of Santiago was very low. Several
programs to improve the quality and delivery of care
have prospectively investigated performance measures
before and after intervention programs around the world
and have described similar results before organizational
interventions in acute stroke care [20,21,27-30].
Table 3 Performance measures, percentage of patients with pneumonia and 30-days case fatality
Measure Number of interventions performed/number indicated % (95% CI)
Percentage of patients with neurological evaluation on admission 389/677 52.4 (48.3-56.5)
Dysphagia screening 84/609* 12.1 (9.7-15.0)
Prescription of antithrombotics at discharge 457/612† 68.9 (64.6-72.9)
Intravenous thrombolysis 15/677 1.70 (1.0-3.0)
In-hospital pneumonia 167/677 23.6 (20.4- 27.2)
30-day case fatality 59/677 8.7 (6.7-11.3)
*68 patients who were unconscious at hospital admission were excluded.
† Patients who died during their hospital stay were excluded.
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of symptom onset in less than 50% of patients and
within 4.5 hours in less than 10%, limiting the possibility
of acute care, especially intravenous thrombolysis or
hemicraniectomy. The literature reveals considerable
variability in arrival times to hospital. In the Paul
Coverdell Registry, the median time from hospital arrival
to brain imaging among all patients was 1 hour, 12 -
minutes (mean: 2 hours, 36 minutes) [27], while in
Korea the median time interval from symptom onset to
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30-day case fatality and 95% confidence interval
Figure 3 Performance and outcome measures by hospital.with the finding of delays from symptom onset to CT
confirmation of diagnosis, intravenous thrombolysis was
administered in only 1.7% of the patients, a lower per-
centage than that in high-income countries [16,19], and
similar to that reported in Argentina and China, where
1.05% and 2.4% of patients with acute ischemic stroke
were treated with intravenous thrombolysis [30,32].
This low use was to be expected, since systematic
organizational changes have not been implemented in
hospitals and thrombolysis is usually administered in
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Table 4 Factors associated with 30-day case-fatality and in-hospital pneumonia, adjusted odds ratios from generalized
estimating equations
30-day case-fatality In-hospital pneumonia
Adjusted OR (95% CI) p-value Adjusted OR (95% CI) p-value
Sex: female 1.48 (0.82-2.27) 0.28 1.55 (1.03-2.33) 0.03
Age (years) 1.08 (1.06-1.10) 0.00 1.04 (1.03-1.05) 0.00
Diagnosis of diabetes 0.53 (0.24-1.15) 0.11 1.79 (1.35-2.38) 0.00
Diagnosis of hypertension 1.90 (0.49-7.30) 0.35 0.82 (0.54-1.24) 0.33
Aphasia on admission 2.42 (1.05-5.61) 0.04 1.97 (1.45-2.69) 0.00
Hemiplegia on admission 0.57 (0.23-1.39) 0.21 1.60 (1.08-2.38) 0.02
Reduced level of consciousness on admission 2.41 (1.32-4.41) 0.00 3.37 (2.07-5.48) 0.00
Speech disturbance on admission 1.39 (1.02-1.90) 0.04 1.24 (0.88-1.74) 0.22
Post-stroke pneumonia 7.65 (314.72) 0.00 - -
Neurological evaluation 2.02 (0.77-5.30) 0.15 1.07 (0.79;1.44) 0.66
Dysphagia screening 0.52 (0.26-1.04) 0.07 1.58 (0.60; 4.15) 0.36
Models adjusted by all factors in this table and clustering of patients by individual hospital.
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ness and accuracy of registration of the times of symp-
tom onset and CT confirmation of diagnosis. Monitoring
the time from symptom onset to the distinct interven-
tions is essential to improve patient care and adherence
to evidence-based performance measures in the acute
management of stroke and to reduce pre-admission and
post-admission barriers to treatment [15]. Of 56,969
patients in the Paul Coverdell Registry, the time from
symptom onset to hospital arrival was unknown or not
recorded in 57.8% [27].
This study shows that clinical neurological evaluation
measures such as the National Institute of Health Stroke
Scale (NIHSS) have not been incorporated in routine
clinical practice in the emergency departments of the
hospitals in the sample. The NIHSS has established val-
idity and reliability for use in the clinical evaluation of
stroke patients and is strongly predictive of early func-
tional recovery and long-term outcome. This scale can
be administered by physicians, research workers, and
nurses alike and has proven intra- and inter-rater
reliability [33]. In addition to the low use of the NIHSS,
we also found that early evaluation of neurological def-
icit was not systematically performed in all the hospitals
studied.
Dysphagia screening was particularly low in our study
and could strongly influence the incidence of pneumo-
nia. In the Canadian Stroke Network Registry, dysphagia
screening was performed in 56% of patients [28]. A
study using the Paul Coverdell Registry showed that un-
screened patients were at a higher risk of pneumonia
than screened patients [34].
In the present study, more than one-fifth of the pa-
tients developed in-hospital pneumonia. Post-stroke
pneumonia is a potentially preventable complication thatis associated with poor outcome [35]. In the multivari-
able analysis, the factors associated with pneumonia
were age, female sex, a reduced level of consciousness
on admission, aphasia, hemiplegia and a diagnosis of
diabetes. Neither dysphagia screening nor clinical evalu-
ation care contributed significantly to post-stroke pneu-
monia. Dysphagia screening was carried out in a very
small proportion of patients and could not fully be eval-
uated in the multivariable model. Clinical evaluation on
admission, as defined in current clinical practice, was
insufficiently specific to identify other variables with
proven prognostic value in the risk of post-stroke pneu-
monia, such as pre-existing dependency, non-lacunar vs
lacunar stroke, chronic obstructive pulmonary disease
and other factors [36]. Finlayson reported that health
care determinants, such as stroke unit admission did not
predict the occurrence of pneumonia but were, however,
associated with decreased mortality from this infection,
indicating the need to intensify acute stroke care [36].
Like Aslayen et al. [37], we found an increased risk of
pneumonia in women and patients with diabetes, which
could be explained by the higher risk of infections in
diabetic patients.
Among secondary prevention measures, compliance with
recommendations on the prescription of antithrombotic
agents at discharge was lower than expected and these
drugs were not prescribed in a third of the eligible patients;
variations among hospitals were also found. This finding is
particularly worrisome as prescription of these drugs at
discharge is one of the most widely used and cheapest sec-
ondary preventive measures. In most registries, compliance
with this performance measure was usually above 90% in
both high- and low-medium income countries [20,21,30].
Likewise, no record was found in the medical charts of dis-
ability evaluation at discharge or the need for community-
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formance measures of acute stroke care, both measures are
associated with improved outcomes [38].
The case fatality rates in our study are similar to the
mean case fatality rates reported in countries belonging
to the Organization for Economic Cooperation and
Developmet (OECD) [39]. Like other studies [35], we
found that the factors that contributed to explaining the
likelihood of death at 30 days were pneumonia, age [36],
speech disturbance, reduced level of consciousness and
aphasia. Nevertheless, the two interventions selected did
not have a significant effect on this outcome.
Our study has several limitations that could bias the
results. We were unable to retrieve 17.5% of the sample
because of the poor quality of medical registration in the
patients’ charts and the impossibility of retrieving the
charts in one hospital after the 2010 earthquake. How-
ever, no difference was found by demographic character-
istics and 30-day fatality between patients included in
the sample and those not included. Therefore, we believe
that the probability of selection bias is small and that
our results reflect the reality of stroke care in these
hospitals. Nevertheless, they may not reflect the care in
hospitals in more isolated and less populated regions of
the country, where standards could be lower and out-
comes poorer, as shown in rural Australia by Cadilhac
et al. [40].
Another limitation of this study is that we could not
measure the effect of organized patient care (stroke
units) as these facilities are only recently being
implemented in some public hospitals in the Metro-
politan Region of Santiago. In addition, we had no
standardised summary measure of stroke severity
such as the NIHSS and relied on other objective
clinical measures at time of admission to account for
stroke severity in our statistical models.
A strength of this study is that we were able to obtain
data from hospitals admitting more that 50% of all
patients with ischemic stroke in the country. We believe
the findings of this study have good external validity for
Chile as the age and sex distribution of the patients
included was similar to those of the patients in the only
community-based stroke study published to date the
PISCIS study [3].
Conclusions
This is the first study to reveal the low implementation
and adherence to evidence-based performance measures
in hospitals admitting more than 50% of all ischemic
stroke patients in Chile. These measures are part of the
National Chilean Clinical Practice Guidelines for stroke,
and reimbursement is guaranteed by health insurance
agencies for some recommendations such as the use of
CT scanning and thrombolytic therapy. We hope thatthese results will encourage decision makers to imple-
ment surveillance registries and modify the organization
of health services that provide care to patients with
stroke; in other countries, such actions have shown
promising results in a relatively short term [6,19,21].
Furthermore, to increase the possibility of hyperacute
interventions such as thrombolysis in a larger popula-
tion, programs directed at lowering the barriers to
prompt diagnosis and arrival at emergency departments
should be designed and implemented.
Competing interests
The authors have no conflicts of interest.
Authors’ contributions
LH made substantial contributions to the conception and design of the
study, data collection and analysis, interpretation of the results and drafting
of the manuscript. PL substantially contributed to the conception and design
of the study, analysis and interpretation of the results and drafting of the
manuscript. CV performed the data analysis, participated in data collection,
interpretation and preparation of the results and contributed to the drafting
of the manuscript. MC substantially contributed to the data analysis,
preparation and interpretation of the results, and review of the manuscript.
RC contributed to the study design, data collection and its monitoring and
interpretation of the results and collaborated in the drafting of the
manuscript. XC substantially contributed to the conception and design of
the study and interpretation of the results and participated in the drafting of
the manuscript. All the authors have reviewed and approved the final
version of the manuscript.
Authors’ information
We wish to highlight some relevant information about the authors: PL is a
neurologist with a Master’s in Public Health, and was the main researcher of
the PISCIS project, a community-based study of the incidence of stroke in
Chile, whose results were published in indexed journals. XC is and PhD with
vast experience in research and health service systems. LH has a Master’s in
Public Health, is a Ph.D. candidate in Biomedicine and works at the School of
Public Health in the Universidad Mayor of Chile.
Acknowledgements
This study was partially supported by the Ministry of Health of Chile which
helped to find the study design and data collection, and by the University
Mayor of Chile, which helped to fund the authors involved in data analysis
and drafting of the manuscript, as well as its publication.
Author details
1School of Public Health, Facultad de Medicina, Universidad Mayor, Santiago,
Chile. 2Neurology Service, Clínica Alemana de Santiago, Universidad del
Desarrollo, Santiago, Chile. 3Department of Neurological Sciences, Facultad
de Medicina, Universidad de Chile, Santiago, Chile. 4Department of
Epidemiology and Evaluation, Hospital del Mar, Barcelona; IMIM (Hospital del
Mar Medical Research Institute), Barcelona; Red de Investigación en Servicios
de Salud en Enfermedades Crónicas (REDISSEC), Mar Teaching Hospital,
25-29 Passeig Marítim, 08003, Barcelona, Spain.
Received: 20 September 2012 Accepted: 27 February 2013
Published: 6 March 2013
References
1. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V: Worldwide
stroke incidence and early case fatality reported in 56 population-based
studies: a systematic review. Lancet Neurol 2009, 8:355–369.
2. Johnston SC, Mendis S, Mathers CD: Global variation in stroke burden and
mortality: estimates from monitoring, surveillance, and modelling. Lancet
Neurol 2009, 8:345–354.
3. Lavados PM, Sacks C, Prina L, Escobar A, Tossi C, Araya F, et al: Incidence,
30-day case-fatality rate, and prognosis of stroke in Iquique, Chile: a 2-
Hoffmeister et al. BMC Neurology 2013, 13:23 Page 10 of 10
http://www.biomedcentral.com/1471-2377/13/23year community-based prospective study (PISCIS project). Lancet 2005,
365:2206–2215.
4. Lavados PM, Sacks C, Prina L, Escobar A, Tossi C, Araya F, et al: Incidence,
case-fatality rate, and prognosis of ischaemic stroke subtypes in a
predominantly Hispanic-Mestizo population in Iquique, Chile (PISCIS
project): a community-based incidence study. Lancet Neurol 2007,
6:140–148.
5. Govan L, Weir CJ, Langhorne P: Organized Inpatient (Stroke Unit) Care for
Stroke. Stroke 2008, 39:2402–2403.
6. Cadilhac DA, Pearce DC, Levi CR, Donnan GA: Improvements in the quality
of care and health outcomes with new stroke care units following
implementation of a clinician-led, health system redesign programme in
New South Wales, Australia. Qual Saf Health Care 2008, 17:329–333.
7. Donnan GA, Fisher M, Macleod M, Davis SM: Stroke. Lancet 2008, 371:1612–1623.
8. The National Institute of Neurological Disorders and Stroke rt-PA Stroke
Study Group: Tissue plasminogen activator for acute ischemic stroke.
N Engl J Med 1995, 333:1581–1587.
9. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al:
Guidelines for the early management of adults with ischemic stroke:
a guideline from the American Heart Association/American Stroke
Association Stroke Council, Clinical Cardiology Council, Cardiovascular
Radiology and Intervention Council, and the Atherosclerotic Peripheral
Vascular Disease and Quality of Care Outcomes in Research
Interdisciplinary Working Groups: the American Academy of Neurology
affirms the value of this guideline as an educational tool for
neurologists. Stroke 2007, 38:1655–1711.
10. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al:
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
N Engl J Med 2008, 359:1317–1329.
11. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al: Time
to treatment with intravenous alteplase and outcome in stroke: an
updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
Lancet 2010, 375:1695–1703.
12. Ministry of Health of Chile: Clinical Guidelines of acute ischemic stroke in
adults (15 years and older). http://www.redsalud.gov.cl/archivos/guiasges/
isquemico.pdf.
13. The European Stroke Organization (ESO) Executive Committee and the ESO
Writing Committee: Guidelines for Management of Ischaemic Stroke and
Transient Ischaemic Attack 2008. http://www.eso-stroke.org/pdf/
ESO08_Guidelines_English.pdf.
14. National Stroke Foundation: Clinical Guidelines for Acute Stroke Management.
Australia: 2010. http://www.strokefoundation.com.au.
15. Eissa A, Krass I, Bajorek BV: Optimizing the management of acute
ischaemic stroke: a review of the utilization of intravenous recombinant
tissue plasminogen activator (tPA). J Clin Pharm Ther 2012, 37:620–629.
16. National Stroke Foundation: National Stroke Audit Acute Services Clinical
Audit Report. 2011. http://www.strokefoundation.com.au.
17. Kleindorfer D, Xu Y, Moomaw CJ, Khatri P, Adeoye O, Hornung R: US geographic
distribution of rt-PA utilization by hospital for acute ischemic stroke.
Stroke 2009, 40:3580–3584.
18. Wasay M, Barohi H, Malik A, Yousuf A, Awan S, Kamal AK: Utilization and
outcome of thrombolytic therapy for acute stroke in Pakistan. Neurol Sci
2010, 31:223–225.
19. Fonarow GC, Reeves MJ, Smith EE, Saver JL, Zhao X, Olson DW, et al:
Characteristics, performance measures, and in-hospital outcomes of the
first one million stroke and transient ischemic attack admissions in get
with the guidelines-stroke. Circ Cardiovasc Qual Outcomes 2010, 3:291–302.
20. Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, et al:
Get With the Guidelines-Stroke is associated with sustained
improvement in care for patients hospitalized with acute stroke or
transient ischemic attack. Circulation 2009, 119:107–115.
21. Abilleira S, Ribera A, Sanchez E, Tresserras R, Gallofre M: The Second Stroke
Audit of Catalonia shows improvements in many, but not all quality
indicators. Int J Stroke 2012, 7:19–24.
22. Teasdale G, Jennett B: Assessment of coma and impaired consciousness.
A practical scale. Lancet 1974, 2:81–84.
23. National Institute of Statistics: Mortality Trends in Chile of death causes and
age, 1990–2007. http://www.ine.cl/canles/menu/publicaciones/
calendario_de_publicaciones/pdf/010211evo90_70_010211.pdf.24. Saposnik G, Hill MD, O'Donnell M, Fang J, Hachinski V, Kapral MK: Variables
associated with 7-day, 30-day, and 1-year fatality after ischemic stroke.
Stroke 2008, 39:2318–2324.
25. Reid JM, Gubitz GJ, Dai D, Kydd D, Eskes G, Reidy Y, et al: Predicting
functional outcome after stroke by modelling baseline clinical and CT
variables. Age Ageing 2010, 39:360–366.
26. Landis JR, Koch GG: The measurement of observer agreement for
categorical data. Biometrics 1977, 33:159–174.
27. George MG, Tong X, McGruder H, Yoon P, Rosamond W, Winquist A, et al:
Paul Coverdell National Acute Stroke Registry Surveillance - four states,
2005–2007. MMWR Surveill Summ 2009, 58:1–23.
28. Saposnik G, Black SE, Hakim A, Fang J, Tu JV, Kapral MK: Age disparities in
stroke quality of care and delivery of health services. Stroke 2009,
40:3328–3335.
29. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, Hermanek P, Leffmann
C, Janzen RW, et al: Predictors of in-hospital mortality and attributable
risks of death after ischemic stroke: the German Stroke Registers Study
Group. Arch Intern Med 2004, 164:1761–1768.
30. Sposato LA, Esnaola MM, Zamora R, Zurru MC, Fustinoni O, Saposnik G:
Quality of ischemic stroke care in emerging countries: the Argentinian
National Stroke Registry (ReNACer). Stroke 2008, 39:3036–3041.
31. Kim JS, Lee KB, Roh H, Ahn MY, Hwang HW: Gender differences in the
functional recovery after acute stroke. J Clin Neurol 2010, 6:183–188.
32. Wang Y, Liao X, Zhao X, Wang DZ, Wang C, Nguyen-Huynh MN, et al: Using
recombinant tissue plasminogen activator to treat acute ischemic stroke
in China: analysis of the results from the Chinese National Stroke
Registry (CNSR). Stroke 2011, 42:1658–1664.
33. Prasad K, Dash D, Kumar A: Validation of the Hindi version of National
Institute of Health Stroke Scale. Neurol India 2012, 60:40–44.
34. Lakshminarayan K, Tsai AW, Tong X, Vazquez G, Peacock JM, George
MG, et al: Utility of dysphagia screening results in predicting
poststroke pneumonia. Stroke 2010, 41:2849–2854.
35. Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D:
Post-stroke infection: a systematic review and meta-analysis. BMC Neurol
2011, 11:110.
36. Finlayson O, Kapral M, Hall R, Asllani E, Selchen D, Saposnik G: Risk factors,
inpatient care, and outcomes of pneumonia after ischemic stroke.
Neurology 2011, 77:1338–1345.
37. Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR: Pneumonia and urinary
tract infection after acute ischaemic stroke: a tertiary analysis of the
GAIN International trial. Eur J Neurol 2004, 11:49–53.
38. Hubbard IJ, Harris D, Kilkenny MF, Faux SG, Pollack MR, Cadilhac DA:
Adherence to clinical guidelines improves patient outcomes in
Australian audit of stroke rehabilitation practice. Arch Phys Med Rehabil
2012, 93:965–971.
39. Organization for Economic Cooperation and Development: Health at a
Glance 2001. OECD Indicators. http://www.oecd.org/health/healthataglance.
40. Cadilhac DA, Kilkenny MF, Longworth M, Pollack MR, Levi CR: Metropolitan-
rural divide for stroke outcomes: do stroke units make a difference?
Intern Med J 2011, 41:321–326.
doi:10.1186/1471-2377-13-23
Cite this article as: Hoffmeister et al.: Performance measures for in-
hospital care of acute ischemic stroke in public hospitals in Chile. BMC
Neurology 2013 13:23.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
